Evaluation of the biometric value of observational gait scales - Wisconsin Gait Scale and Gait Abnormality Rating Scale – modified in neurological diseases
Completed
- Conditions
- multiple sclerosisstrokehemiplegic gait
- Registration Number
- ACTRN12618000494235
- Lead Sponsor
- niversity of Rzeszow
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie gait abnormalities in multiple sclerosis and ischemic stroke patients?
How does the Wisconsin Gait Scale compare to standard gait assessment tools in MS and stroke populations?
Are there specific biomarkers that correlate with gait scale scores in neurological diseases like MS and stroke?
What adverse events are commonly associated with gait rehabilitation strategies in multiple sclerosis and post-stroke patients?
What combination therapies are being explored to improve gait in hemiplegic stroke and MS patients alongside observational scales?